George Jones - 15 Sep 2025 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role
Chief Commercial Officer
Signature
/s/ Daniel Hakansson, Attorney-in-fact for George Jones
Issuer symbol
BFRI
Transactions as of
15 Sep 2025
Net transactions value
$0
Form type
4
Filing time
16 Sep 2025, 21:25:47 UTC
Previous filing
16 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jones George Patrick Chief Commercial Officer 120 PRESIDENTIAL WAY SUITE 330, WOBURN, /s/ Daniel Hakansson, Attorney-in-fact for George Jones 16 Sep 2025 0002085560

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Employee stock option (right to buy) Award $0 +100,000 $0.000000 100,000 15 Sep 2025 Common Stock 100,000 $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in two equal installments, the first of which will be February 25, 2026 and the second of which will be on August 25, 2026.